<HTML>
<HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">
<DIV style="font-size: 10pt">
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>

<P style="font-size: 14pt" align="center"><B>UNITED STATES<BR>
SECURITIES AND
EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P style="font-size: 18pt" align="center"><B>FORM 8-K</B>

<P style="font-size: 12pt" align="center"><B>CURRENT REPORT<BR>
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P style="font-size: 10pt" align="center"><B>Date of Report (Date of earliest
event reported): May 28, 2009</B>

<P style="font-size: 24pt" align="center"><B>MEDCO HEALTH SOLUTIONS,
INC.<BR>
</B><FONT style="font-size: 10pt">(Exact name of registrant as
specified in its charter) </FONT>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="32%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="33%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="32%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>Delaware</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>1-31312</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>22-3461740</B></TD>
 </TR>
 <TR valign="top">
  <TD>(State or other Jurisdiction of Incorporation)</TD>
  <TD>&nbsp;</TD>
  <TD>(Commission File Number)</TD>
  <TD>&nbsp;</TD>
  <TD>(IRS Employer Identification No.)</TD>
 </TR>

</TABLE>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="49%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="49%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>100 Parsons Pond Drive,
Franklin Lakes, NJ <BR>
</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>07417</B></TD>
 </TR>
 <TR valign="top">
  <TD>(Address of Principal Executive Offices)</TD>
  <TD>&nbsp;</TD>
  <TD>(Zip Code)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="center">Registrant&#8217;s telephone number,
including area code: <B>201-269-3400</B>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="30%" border="0">

 <TR>
  <TD width="100%">&nbsp;</TD>
 </TR>
 <TR>
  <TD style="border-bottom: #000000 1px solid" nowrap><B>&nbsp;</B></TD>
 </TR>
 <TR>
  <TD nowrap>(Former name or former address if changed since last report.)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="left">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:

<P style="font-size: 10pt" align="left"><FONT face="Wingdings">o</FONT> Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)<BR>
<BR>
<FONT face="Wingdings">o</FONT> Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>


<DIV
style="margin-top: 10pt; font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="left"><B>Item&nbsp;7.01 Regulation&nbsp;FD
Disclosure.</B>

<P style="font-size: 10pt; text-indent: 4%" align="left">Senior members of
Medco Health Solutions, Inc.&#8217;s (the &#8220;Company&#8221;) management
team will be making a presentation at the Sanford C. Bernstein &amp; Co. LLC
25th Annual Strategic Decision Conference 2009 on Thursday, May&nbsp;28, 2009
at 9:00 a.m. Eastern Time in New York City. A live audio webcast of the
Company&#8217;s presentation at the conference will be available on the
Company&#8217;s Investor Relations website at
<U>www.medcohealth.com/investor</U>. A replay of the Company&#8217;s
presentation will also be available on the Company&#8217;s website for one
month following the presentation. The slides accompanying the presentation are
attached to this Current Report on Form 8-K (&#8220;Current Report&#8221;) as
Exhibit&nbsp;99.1 and are incorporated herein solely for purposes of this
Item&nbsp;7.01 disclosure. These materials will also be available on the
Company&#8217;s Investor Relations website at
<U>www.medcohealth.com/investor</U>.

<P style="font-size: 10pt; text-indent: 4%" align="left">The information in
Item&nbsp;7.01 of this Current Report, including Exhibit&nbsp;99.1 attached
hereto, is being furnished and shall not be deemed &#8220;filed&#8221; for
purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended,
or otherwise subject to the liabilities of such section. The information in
Item&nbsp;7.01 of this Current Report, including Exhibit&nbsp;99.1 attached
hereto, shall not be incorporated by reference into any registration statement
or other document pursuant to the Securities Act of 1933, as amended.

<P style="font-size: 10pt" align="left"><U>Item&nbsp;9.01 Financial Statements
and Exhibits. </U>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="8%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="87%">&nbsp;</TD>
 </TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">Exhibit&nbsp;No. </DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Description</TD>
 </TR>
 <TR style="font-size: 1px">
  <TD style="border-top: #000000 1px solid" valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">&nbsp;</DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD style="border-top: #000000 1px solid" valign="top"
align="left">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">99.1 </DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Slide Presentation for Sanford C. Bernstein
&amp; Co. LLC 25th Annual Strategic Decision Conference 2009 on Thursday,
May&nbsp;28, 2009</TD>
 </TR>
<!-- End Table Body -->

</TABLE>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="center"><U>SIGNATURES</U>

<P style="font-size: 10pt; text-indent: 4%" align="left">Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="48%">&nbsp;</TD>
  <TD width="4%">&nbsp;</TD>
  <TD width="48%">&nbsp;</TD>
 </TR>
<!-- End Table Head -->

<!-- Begin Table Body -->

 <TR valign="bottom">
  <TD>&nbsp;</TD>
  <TD valign="top" align="left" colspan="2">MEDCO HEALTH SOLUTIONS, INC.</TD>
</TR>

<TR><TD>&nbsp;</TD></TR>

 <TR valign="bottom">
  <TD valign="top"><DIV style="margin-left: 0px; text-indent: 0px">Date: May&nbsp;28, 2009 </DIV></TD>
  <TD valign="top" align="left">By: </TD>
  <TD valign="top" align="left" style="border-bottom: #000000 1px solid">/s/ Thomas M. Moriarty</TD>
 </TR>

 <TR valign="bottom">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Thomas M. Moriarty<BR>
General Counsel, Secretary and<br>Senior Vice President,<br>Pharmaceutical
Strategies and Solutions</TD>
 </TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P>
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">

</TABLE>


<P style="font-size: 10pt" align="center">EXHIBIT INDEX

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="8%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="87%">&nbsp;</TD>
 </TR>
<!-- End Table Head -->
<!-- Begin Table Body -->


 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">Exhibit&nbsp;No. </DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Description</TD>
 </TR>
 <TR style="font-size: 1px">
  <TD style="border-top: #000000 1px solid" valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">&nbsp;</DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD style="border-top: #000000 1px solid" valign="top"
align="left">&nbsp;</TD>
 </TR>
 <TR valign="top">
  <TD nowrap align="left">99.1</TD>
  <TD>&nbsp;</TD>
  <TD align="left">Slide Presentation for Sanford C. Bernstein &amp; Co. LLC 25th Annual
Strategic Decision Conference 2009 on Thursday, May&nbsp;28, 2009</TD>
 </TR>

</TABLE>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">4
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c86187e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 10297}]
{"company-data": {"conformed-name": "MEDCO HEALTH SOLUTIONS INC", "cik": "0001170650", "assigned-sic": "5912", "irs-number": "223461740", "state-of-incorporation": "DE", "fiscal-year-end": "1227"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-31312", "film-number": "09855956"}, "business-address": {"street1": "100 PARSONS POND DR", "city": "FRANKLIN LAKES", "state": "NJ", "zip": "07417", "phone": "2012693400"}, "mail-address": {"street1": "100 PARSONS POND DR", "city": "FRANKLIN LAKES", "state": "NJ", "zip": "07417"}, "former-company": [{"former-conformed-name": "MEDCOHEALTH SOLUTIONS INC", "date-changed": "20020528"}, {"former-conformed-name": "MERCK MEDCO MANAGED CARE LLC", "date-changed": "20020404"}]}
Form 8-K
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): May 28, 2009
MEDCO HEALTH SOLUTIONS,
INC.
(Exact name of registrant as
specified in its charter)
Delaware
1-31312
22-3461740
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
100 Parsons Pond Drive,
Franklin Lakes, NJ
07417
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number,
including area code:
201-269-3400
(Former name or former address if changed since last report.)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD
Disclosure.
Senior members of
Medco Health Solutions, Inc.'s (the "Company") management
team will be making a presentation at the Sanford C. Bernstein & Co. LLC
25th Annual Strategic Decision Conference 2009 on Thursday, May 28, 2009
at 9:00 a.m. Eastern Time in New York City. A live audio webcast of the
Company's presentation at the conference will be available on the
Company's Investor Relations website at
www.medcohealth.com/investor
. A replay of the Company's
presentation will also be available on the Company's website for one
month following the presentation. The slides accompanying the presentation are
attached to this Current Report on Form 8-K ("Current Report") as
Exhibit 99.1 and are incorporated herein solely for purposes of this
Item 7.01 disclosure. These materials will also be available on the
Company's Investor Relations website at
www.medcohealth.com/investor
.
The information in
Item 7.01 of this Current Report, including Exhibit 99.1 attached
hereto, is being furnished and shall not be deemed "filed" for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended,
or otherwise subject to the liabilities of such section. The information in
Item 7.01 of this Current Report, including Exhibit 99.1 attached
hereto, shall not be incorporated by reference into any registration statement
or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01 Financial Statements
and Exhibits.
Exhibit No.
Description
99.1
Slide Presentation for Sanford C. Bernstein
& Co. LLC 25th Annual Strategic Decision Conference 2009 on Thursday,
May 28, 2009
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
MEDCO HEALTH SOLUTIONS, INC.
Date: May 28, 2009
By:
/s/ Thomas M. Moriarty
Thomas M. Moriarty
General Counsel, Secretary and
Senior Vice President,
Pharmaceutical
Strategies and Solutions
EXHIBIT INDEX
Exhibit No.
Description
99.1
Slide Presentation for Sanford C. Bernstein & Co. LLC 25th Annual
Strategic Decision Conference 2009 on Thursday, May 28, 2009